Lithium deficiency and the onset of Alzheimer's disease
Landmark study finding that brain lithium levels are abnormally low in human mild cognitive impairment and Alzheimer's disease tissue, and that lithium is sequestered by amyloid-beta plaques. A lithium-deficient diet induced Alzheimer's-like pathology in mice, and of 16 lithium salts tested, lithium orotate uniquely evaded plaque sequestration and reversed pathology from amyloid/tau burden to cognitive deficits.
Evidence
6/10
Moderate Evidence
Sample
—
subjects
Duration
—
study period
Journal
Nature
Aug 2025
Key Findings
- 01
Brain lithium is depleted early in human MCI/Alzheimer's tissue, preceding overt pathology
- 02
Amyloid-beta plaques sequester lithium, depleting it from surrounding neurons and glia
- 03
Dietary lithium restriction induced AD-like transcriptional and pathological changes in mice
- 04
Lithium orotate, uniquely among 16 salts tested, avoided plaque sequestration and reversed pathology in mice
Structured Methods
- Study Design
- Preclinical Study
- Sample Size
- Not reported
- Study Duration
- Not reported
- Methodology
- Not reported
- Limitations
- Core causal and reversal findings are in mice and human autopsy tissue, not living human clinical trial participants. No completed human RCT of lithium orotate exists as of this review.
Citations & References
Aron L, Ngian ZK, Qiu C, Choi J, Liang M, Drake DM, et al. (2025). Lithium deficiency and the onset of Alzheimer's disease. Nature. https://doi.org/10.1038/s41586-025-09335-x
Sample member
Longevity Operator
One number for your longevity journey.
FICO for credit. PHS for longevity. Eight biological domains collapsed into one provable score — intuitive at a glance, rigorous underneath.
- Metabolic
- Hormonal
- Cardiovascular
- Brain / Cognitive
- Sleep
- Musculoskeletal
- Gut
- Immunity / Inflammation
